Patents Represented by Attorney, Agent or Law Firm Kenneth M. Goldman
  • Patent number: 5401465
    Abstract: A luminometer comprising a tray for receiving an array of sample wells, a photodetector assembly, and device for relatively moving the tray and photodetector assembly in one direction to align the sample wells received by the tray in a predetermined sequence with the photodetector assembly. The photodetector assembly of the luminometer includes a stage, a photodetection head having a detection aperture permitting passage of light therethrough, a device for mounting the photodetection head to the stage that permits movement of the head in a direction substantially normal to the direction of relative tray and photodetector assembly movement, and a device for biasing the photodetection head toward a selected sample well so that the detection aperture is substantially isolated from light emitted from adjacent wells. Internal and external photodetector calibration systems and a sample heater are also contemplated.
    Type: Grant
    Filed: May 5, 1992
    Date of Patent: March 28, 1995
    Assignee: Chiron Corporation
    Inventors: Rick T. Smethers, Brian D. Warner, Victor P. Burolla
  • Patent number: 5400102
    Abstract: A reversible, deformable camera carrying case is disclosed wherein the latch for closing the case is formed by two flaps that wrap around the lenspiece. This case is especially useful for holding a camera having a longer lens. A clipping device attached to the case to ensure the camera is not separated from the case is also disclosed.
    Type: Grant
    Filed: January 21, 1993
    Date of Patent: March 21, 1995
    Inventor: Philip M. Alwitt
  • Patent number: 5382512
    Abstract: The invention describes an assay device and assembly for detecting an analyte in a liquid sample. Each assay device in the assembly includes structure defining a well, a ligand-coated particle, and a flexible particle retaining structure for holding the particle in a captured position within the well.
    Type: Grant
    Filed: August 23, 1993
    Date of Patent: January 17, 1995
    Assignee: Chiron Corporation
    Inventors: Rick T. Smethers, Brian D. Warner
  • Patent number: 5380833
    Abstract: Novel methods for assaying a nucleic acid analyte are provided, which employ polynucleotides having oligonucleotide sequences substantially homologous to a sequence of interest in the analyte, where the presence or absence of hybridization at a predetermined stringency provides for the release of a label from a support. Particularly, various techniques are employed for binding a label to a support, whereupon cleavage of either a single or double strand, a label may be released from a support, where the release of the label can be detected as indicative of the presence of a particular oligonucleotide sequence in a sample. The method finds use in diagnosis of disease, genetic monitoring, and analysis of nucleic acid mixtures.
    Type: Grant
    Filed: December 13, 1991
    Date of Patent: January 10, 1995
    Assignee: Chiron Corporation
    Inventor: Michael S. Urdea
  • Patent number: 5372928
    Abstract: Two new isolates of the Hepatitis C virus (HCV), J1 and J7, are disclosed. These new isolates comprise nucleotide and amino acid sequences which are distinct from the prototype HCV isolate, HCV1. Thus, J1 and J7 provide new polynucleotides and polypeptides for use, inter alia, in diagnostics, recombinant protein production and vaccine development.
    Type: Grant
    Filed: February 24, 1994
    Date of Patent: December 13, 1994
    Assignees: Chiron Corporation, The Director General of the National Institute of Health of Japan
    Inventors: Tatsuo Miyamura, Izumi Saito, Michael Houghton, Amy J. Weiner, Jang Han, Janice A. Kolberg, Tai-An Cha, Bruce D. Irvine
  • Patent number: 5371017
    Abstract: The protease necessary for polyprotein processing in Hepatitis C virus is identified, cloned, and expressed. Proteases, truncated protease, and altered proteases are disclosed which are useful for cleavage of specific polypeptides, and for assay and design of antiviral agents specific for HCV.
    Type: Grant
    Filed: April 4, 1991
    Date of Patent: December 6, 1994
    Assignee: Chiron Corporation
    Inventors: Michael Houghton, Qui-Lim Choo, George Kuo
  • Patent number: 5359100
    Abstract: Linear or branched oligonucleotide multimers useful as amplifiers in biochemical assays which comprise (1) at least one first single-stranded oligonucleotide unit that is complementary to a single-stranded oligonucleotide sequence of interest, and (2) a multiplicity of second single-stranded oligonucleotide units that are complementary to a single-stranded labeled oligonucleotide. Amplified sandwich nucleic acid hybridizations and immunoassays using the multimers are exemplified.
    Type: Grant
    Filed: August 13, 1993
    Date of Patent: October 25, 1994
    Assignee: Chiron Corporation
    Inventors: Michael S. Urdea, Brian Warner, Joyce A. Running, Janice A. Kolberg, Jennifer M. Clyne, Ray Sanchez-Pescador, Thomas Horn
  • Patent number: 5332845
    Abstract: Novel phosphorylating reagents are provided which are useful in DNA synthesis and purification procedures. The reagents are substituted phosphines which are particularly useful in the phosphorylation of nucleoside and solid supported oligonucleotides at the 5'-hydroxyl position. Phosphorylation using these reagents is easily and accurately monitored colorimetrically.
    Type: Grant
    Filed: February 26, 1993
    Date of Patent: July 26, 1994
    Assignee: Chiron Corporation
    Inventors: Michael S. Ureda, Thomas Horn
  • Patent number: 5324655
    Abstract: A virion expression system for a desired protein packaged in an envelope derived from a retrovirus useful in administering proteins which cross cell membranes in order to serve their function. Preferred virions are those that carry an RNA sequence that encodes cytokines or lymphokines, and includes IL-2, multiple drug resistance protein, and TNF. Particularly disclosed is a DNA construct in which a gene encoding tumor necrosis factor (TNF) is directly linked to DNA encoding a human .gamma.-interferon signal peptide.
    Type: Grant
    Filed: February 18, 1992
    Date of Patent: June 28, 1994
    Assignee: Cetus Oncology Corporation
    Inventors: Michael Kriegler, Carl Perez
  • Patent number: 5281698
    Abstract: The present invention is a process for preparing an activated ester of polyethylene glycol or a polyoxyethylated polyol. After the activated ester is prepared, it can be reacted with a protein to form a polymer/protein conjugate. Conjugation with a polymer can reduce the protein's immunogenicity, increase its solubility, and increase its circulating in vivo half-life. Preferred proteins are IL-2, CSFs, and interferons.
    Type: Grant
    Filed: July 23, 1991
    Date of Patent: January 25, 1994
    Assignee: Cetus Oncology Corporation
    Inventor: Danute E. Nitecki
  • Patent number: 5266688
    Abstract: The present invention provides recombinant polynucleotides which encode glucose oxidase (GO). It also provides recombinant expression systems which produce, and when desired, secrete active GO and GO analogs into the extracellular medium.
    Type: Grant
    Filed: March 6, 1992
    Date of Patent: November 30, 1993
    Assignee: Chiron Corporation
    Inventor: Steven Rosenberg
  • Patent number: 5258506
    Abstract: Novel photolabile photochemical reagents are disclosed. The reagents are useful in a variety of biochemical and chemical contexts, including nucleic hybridization assays and chemical phosphorylation of hydroxyl-containing compounds. The reagents are particularly useful for introducing cleavable sites into oligonucleotide or polynucleotide chains, i.e., sites which are cleavable upon photolysis. The reagents are also useful in both 5'- and 3'-phosphorylation of oligonucleotide or polynucleotide chains.
    Type: Grant
    Filed: August 25, 1989
    Date of Patent: November 2, 1993
    Assignee: Chiron Corporation
    Inventors: Michael S. Urdea, Thomas Horn
  • Patent number: 5256549
    Abstract: Oligomers and polymers are prepared substantially free of error sequences by sequentially adding monomers, which are terminally blocked and have active functionalities protected, to a growing chain bound to a support through a selectively cleavable linkage. After each addition, unblocked terminal groups are capped. At the completion of monomer addition, enzymatic hydrolysis interfering protecting groups are removed along with the capping group and failure sequences enzymatically degraded. The terminal blocking group may then be removed. The completed oligomer or polymer may be cleaved from the support prior or subsequent to enzymatic degradation but after completion of the sequence.
    Type: Grant
    Filed: April 27, 1990
    Date of Patent: October 26, 1993
    Assignee: Chiron Corporation
    Inventors: Michael S. Urdea, Thomas Horn
  • Patent number: 5101974
    Abstract: A reversible, deformable camera carrying case is disclosed wherein the latch for closing the case is inherent in the case material in the form of an aperture. A clipping device attached to the case to ensure the camera is not separated from the case is also disclosed.
    Type: Grant
    Filed: December 14, 1990
    Date of Patent: April 7, 1992
    Inventor: Phil Alwitt